Objective: The fenestrated Anaconda endograft (Vascutek, Renfrewshire, Scotland) was introduced in 2010 and showed promising short-term results with high technical success and low morbidity rates. The aim of this study was to present the midterm results, with a minimum of 12 months follow-up, for all patients treated with the fenestrated Anaconda endograft in The Netherlands. Methods: Patients treated with the fenestrated Anaconda endograft between May 2011 and February 2015 were included. Follow-up consisted of computed tomography angiography at 1 month and 1 year, and duplex ultrasound yearly thereafter with additional computed tomography angiography if indicated using a standard protocol. Results: A total of 60 patients were included; 48...
BACKGROUND: The aim of the present study was to evaluate the early and mid-term results of the endov...
Objective. To evaluate the peri-operative results of Anaconda endograft in the first 49 cases treate...
Purpose: To report the outcomes of fenestrated endovascular aneurysm repair (FEVAR) and compare earl...
Objective The fenestrated Anaconda endograft (Vascutek, Renfrewshire, Scotland) was introduced in 20...
Objective: In the past decennium, the management of short-neck infrarenal and juxtarenal aortic aneu...
ObjectiveIn the past decennium, the management of short-neck infrarenal and juxtarenal aortic aneury...
Objective: To date, information on the fenestrated Anaconda endograft is limited to case series with...
Objective: The objective of this study was to evaluate early and late results of the Anaconda aortic...
OBJECTIVE: The objective of this study was to evaluate early and late results of the Anaconda aor...
Purpose: To report operative and midterm outcomes of fenestrated endovascular aneurysm repair (FEVAR...
WOS: 000399391600019Purpose: In this study, we aim to report our midterm results of endovascular rep...
Objective: The aim was to describe the outcomes of the Anaconda™ Fenestrated endograft Italian Regis...
BACKGROUND: The AnacondaTM Fenestrated endograft (Vascutek, Inchinnan, UK) is a new device that coul...
BACKGROUND: The aim of the present study was to evaluate the early and mid-term results of the endov...
Objective. To evaluate the peri-operative results of Anaconda endograft in the first 49 cases treate...
Purpose: To report the outcomes of fenestrated endovascular aneurysm repair (FEVAR) and compare earl...
Objective The fenestrated Anaconda endograft (Vascutek, Renfrewshire, Scotland) was introduced in 20...
Objective: In the past decennium, the management of short-neck infrarenal and juxtarenal aortic aneu...
ObjectiveIn the past decennium, the management of short-neck infrarenal and juxtarenal aortic aneury...
Objective: To date, information on the fenestrated Anaconda endograft is limited to case series with...
Objective: The objective of this study was to evaluate early and late results of the Anaconda aortic...
OBJECTIVE: The objective of this study was to evaluate early and late results of the Anaconda aor...
Purpose: To report operative and midterm outcomes of fenestrated endovascular aneurysm repair (FEVAR...
WOS: 000399391600019Purpose: In this study, we aim to report our midterm results of endovascular rep...
Objective: The aim was to describe the outcomes of the Anaconda™ Fenestrated endograft Italian Regis...
BACKGROUND: The AnacondaTM Fenestrated endograft (Vascutek, Inchinnan, UK) is a new device that coul...
BACKGROUND: The aim of the present study was to evaluate the early and mid-term results of the endov...
Objective. To evaluate the peri-operative results of Anaconda endograft in the first 49 cases treate...
Purpose: To report the outcomes of fenestrated endovascular aneurysm repair (FEVAR) and compare earl...